The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This is the one of the the hardest stock to predict. Lexapro is the 2nd most prescribed drug in America. Government rules regarding patents mean the drug will go generic in 2012. This means FRX's major revenue stream will dry up. In 2011 people will start selling. Until then it's do well. With no end in sight for the recession people will continue to be depressed and doctors will prescribe anti-depressant. There is plenty of research on the relationship between recessions (or future outlooks) and depression